False Activations for ST-Segment Elevation Myocardial Infarction

David C. Lange, Ivan C. Rokos, J. Lee Garvey, David M. Larson, Timothy D Henry

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


First-medical-contact-to-device (FMC2D) times have improved over the past decade, as have clinical outcomes for patients presenting with ST-elevation myocardial infarction (STEMI). However, with improvements in FMC2D times, false activation of the cardiac catheterization laboratory (CCL) has become a challenging problem. The authors define false activation as any patient who does not warrant emergent coronary angiography for STEMI. In addition to clinical outcome measures for these patients, STEMI systems should collect data regarding the total number of CCL activations, the total number of emergency coronary angiograms, and the number revascularization procedures performed.

Original languageEnglish (US)
Pages (from-to)451-469
Number of pages19
JournalInterventional Cardiology Clinics
Issue number4
StatePublished - Oct 1 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc.


  • Assessment
  • False activation
  • Primary percutaneous coronary intervention
  • Quality improvement
  • Quality outcomes
  • ST-elevation myocardial infarction
  • Systems of care


Dive into the research topics of 'False Activations for ST-Segment Elevation Myocardial Infarction'. Together they form a unique fingerprint.

Cite this